FePt Nanoparticles as an Fe Reservoir for Controlled Fe Release and Tumor Inhibition
- 1 October 2009
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 131 (42), 15346-15351
- https://doi.org/10.1021/ja905938a
Abstract
Chemically disordered face centered cubic (fcc) FePt nanoparticles (NPs) show the controlled release of Fe in low pH solution. The released Fe catalyzes H2O2 decomposition into reactive oxygen species within cells, causing fast oxidation and deterioration of cellular membranes. Functionalized with luteinizing hormone-releasing hormone (LHRH) peptide via phospholipid, the fcc-FePt NPs can bind preferentially to the human ovarian cancer cell line (A2780) that overexpresses LHRH receptors and exhibit high toxicity to these tumor cells. In contrast, the fcc-FePt NPs pre-etched in the low pH (4.8) buffer solution show nonappreciable cytotoxicity. The work demonstrates that fcc-FePt NPs may function as a new type of agent for controlled cancer therapy.This publication has 41 references indexed in Scilit:
- Superparamagnetic nanoparticles as targeted probes for diagnostic and therapeutic applicationsDalton Transactions, 2009
- Dumbbell-like Au−Fe3O4 Nanoparticles for Target-Specific Platin DeliveryJournal of the American Chemical Society, 2009
- Magnetic nanoparticles in MR imaging and drug deliveryAdvanced Drug Delivery Reviews, 2008
- Chemical Design of Nanoparticle Probes for High‐Performance Magnetic Resonance ImagingAngewandte Chemie, 2008
- Synthesis and Stabilization of Monodisperse Fe NanoparticlesJournal of the American Chemical Society, 2006
- Free radicals, metals and antioxidants in oxidative stress-induced cancerChemico-Biological Interactions, 2006
- Quantum dot bioconjugates for imaging, labelling and sensingNature Materials, 2005
- Measuring reactive species and oxidative damagein vivoand in cell culture: how should you do it and what do the results mean?British Journal of Pharmacology, 2004
- Applications of magnetic nanoparticles in biomedicineJournal of Physics D: Applied Physics, 2003
- Evaluation of the probe 2',7'-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stressChemical Research in Toxicology, 1992